Windtree Therapeutics, Inc

Windtree Therapeutics is a global, clinical-stage, biopharmaceutical and medical device company focused on the development of novel therapeutics intended to address significant unmet medical needs in important acute care markets. Windtree has four clinical and multiple pre-clinical programs spanning respiratory, cardiovascular and oncology disease states. The Companys lead clinical programs include AEROSURF, a novel med-device combination designed to deliver the companys proprietary synthetic, peptide-containing surfactant non-invasively to premature infants with respiratory distress syndrome (RDS); istaroxime, a first-in-class, dual-acting agent being developed to improve cardiac function in patients with acute heart failure while avoiding the unwanted side effects of existing treatments;...

Respiratory therapies,aerosol drug delivery,surfactant technology,cardiology,acute heart failure,oncology,medical device,research and development,manufacturing,biotechnology,pharmaceutical,neonatology,and hypertension

Windtree therapeutics, inc operates in the Pharmaceutical manufacturing industry.

Windtree therapeutics, inc's revenue is 11m - 100m

Windtree therapeutics, inc has 11 - 50 employees.